Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Ekso Bionics stock | $9.2

Own Ekso Bionics stock in just a few minutes.

Fact checked

Ekso Bionics Holdings, Inc is a medical instruments & supplies business based in the US. Ekso Bionics shares (EKSO) are listed on the NASDAQ and all prices are listed in US Dollars. Ekso Bionics employs 67 staff and has a trailing 12-month revenue of around USD$10.3 million.

How to buy shares in Ekso Bionics

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Ekso Bionics. Find the stock by name or ticker symbol: EKSO. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Ekso Bionics reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$9.2, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Ekso Bionics, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Ekso Bionics. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Ekso Bionics share price

Use our graph to track the performance of EKSO stocks over time.

Ekso Bionics shares at a glance

Information last updated 2020-12-27.
Latest market closeUSD$9.2
52-week rangeUSD$2.25 - USD$9.34
50-day moving average USD$5.3079
200-day moving average USD$5.4039
Wall St. target priceUSD$10
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-0.319

Buy Ekso Bionics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
$0
Stocks, Forex
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Public
$0
Stocks, ETFs
N/A
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Ekso Bionics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Ekso Bionics price performance over time

Historical closes compared with the close of $9.2 from 2021-01-11

1 week (2021-01-15) 12.47%
1 month (2020-12-23) 32.37%
3 months (2020-10-23) 93.28%
6 months (2020-07-23) 28.13%
1 year (2020-01-23) 2,359.89%
2 years (2019-01-23) 457.58%
3 years (2018-01-23) 493.55%
5 years (2016-01-22) 945.45%

Ekso Bionics financials

Revenue TTM USD$10.3 million
Gross profit TTM USD$6.8 million
Return on assets TTM -36.26%
Return on equity TTM -196.6%
Profit margin -140.8%
Book value $1.01
Market capitalisation USD$58 million

TTM: trailing 12 months

Shorting Ekso Bionics shares

There are currently 175,456 Ekso Bionics shares held short by investors – that's known as Ekso Bionics's "short interest". This figure is 7.1% up from 163,844 last month.

There are a few different ways that this level of interest in shorting Ekso Bionics shares can be evaluated.

Ekso Bionics's "short interest ratio" (SIR)

Ekso Bionics's "short interest ratio" (SIR) is the quantity of Ekso Bionics shares currently shorted divided by the average quantity of Ekso Bionics shares traded daily (recently around 108306.17283951). Ekso Bionics's SIR currently stands at 1.62. In other words for every 100,000 Ekso Bionics shares traded daily on the market, roughly 1620 shares are currently held short.

However Ekso Bionics's short interest can also be evaluated against the total number of Ekso Bionics shares, or, against the total number of tradable Ekso Bionics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Ekso Bionics's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Ekso Bionics shares in existence, roughly 20 shares are currently held short) or 0.0195% of the tradable shares (for every 100,000 tradable Ekso Bionics shares, roughly 20 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Ekso Bionics.

Find out more about how you can short Ekso Bionics stock.

Ekso Bionics share dividends

We're not expecting Ekso Bionics to pay a dividend over the next 12 months.

Have Ekso Bionics's shares ever split?

Ekso Bionics's shares were split on a 1:15 basis on 25 March 2020. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Ekso Bionics shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Ekso Bionics shares which in turn could have impacted Ekso Bionics's share price.

Ekso Bionics share price volatility

Over the last 12 months, Ekso Bionics's shares have ranged in value from as little as $2.25 up to $9.34. A popular way to gauge a stock's volatility is its "beta".

EKSO.US volatility(beta: 2.33)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Ekso Bionics's is 2.3349. This would suggest that Ekso Bionics's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Ekso Bionics overview

Ekso Bionics Holdings, Inc. designs, develops, and sells exoskeletons for use in the healthcare, industrial, and military markets in the United States and internationally. The company operates in two segments, EksoHealth and EksoWorks. It primarily offers EksoNR, a bionic suit that provides the ability to stand and walk over ground with a full weight-bearing, reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries and hemiplegia due to stroke; and EksoUE, a wearable assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms, as well as reduce fatigue while rehabilitation sessions to achieve a larger active range of motion. The company's Ekso devices are primarily used in a hospital and rehabilitation setting. It has a license agreement with Lockheed Martin Corporation, Regents of the University of California, and Garrett Brown, as well as with OttoBock Healthcare Products Gmbh. The company was founded in 2005 and is headquartered in Richmond, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site